TechWald Next co-leads RapidPulse USD 48 million Series B round
MDT•RapidPulse raises USD 48 million in Series B
- Techwald Holding SPA-backed TechWald Next co-led RapidPulse’s oversubscribed Series B round, raising USD 48 million.
- RapidPulse develops pulsed aspiration catheter technology for acute ischemic stroke thrombectomy, aiming to improve clot removal.
- Medtronic co-led the financing; S3 Ventures also co-led, with other healthcare investors participating.
Proceeds to support clinical study and FDA filing
Proceeds are earmarked to complete the TURBO IDE study, expand clinical use at stroke centers, and support a potential FDA approval filing.
